Helmholtz Zentrum München studies the pathogenesis of major common diseases, placing special emphasis on diabetes mellitus, lung diseases and allergies. The focus of research is on the interaction between environmental and lifestyle factors and individual genetic disposition during disease development. Through this research to uncover the mechanisms underlying disease, the Center contributes significantly to a better understanding of other common diseases such as immunological and neuropsychiatric diseases and cancer.
With its excellent basic research programs as well as top-level scientific and technical infrastructure, the Center develops innovative approaches to personalized diagnostics, therapy and prevention. International cooperative projects and the active promotion of young scientists make the Center an attractive employer. The collaboration with outstanding partners in hospitals, research institutions and industry enables the bidirectional translation of new insights from basic research to clinical practice and from clinical observations back again to the research laboratory. Through translational centers, clinical cooperation groups and collaborations with industry, advances in knowledge bring about rapid benefits to society. The goal is to develop an approach to medicine that addresses the cause of disease and provides personalized options for prevention, diagnosis and treatment.
Helmholtz Zentrum München is a research institution of the Federal Republic of Germany and the Free State of Bavaria. It is a member of the Helmholtz Association of German Research Centres.